BioCardia, Inc. (NASDAQ:BCDA) Q1 2026 Earnings Call Transcript
BioCardia, Inc. (NASDAQ:BCDA) Q1 2026 Earnings Call Transcript May 15, 2026BioCardia, Inc. misses on earnings expectations. Reported EPS is $-0.21 EPS, expectations were $-0.17.
Biocardia Inc. (BCDA)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Pingora Partners Keith Ohnmeis | 120,382 | $149,274 | +237% | 0.09% |
| 2. | Citadel Investment Group Ken Griffin | 22,956 | $28,465 | -64% | 0% |
| 3. | Renaissance Technologies Jim Simons | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.03 | 1,000 | $1,030.00 | 384,885 | 2026-09-29 | Filing | |
| $1.05 | 1,900 | $1,995.00 | 383,885 | 2026-09-23 | Filing | |
| $1.09 | 800 | $872.00 | 381,985 | 2026-09-03 | Filing | |
| $0.93 | 5,400 | $5,022.00 | 381,115 | 2026-08-17 | Filing | |
| $0.92 | 1,900 | $1,748.00 | 375,785 | 2026-08-13 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.00 | 3,257 | $6,514.00 | 8,968 | 2024-12-20 | Filing | |
| $0.43 | 129,802 | $55,814.86 | 1,896,025 | 2024-01-19 | Filing | |
| $2.31 | 3,200 | $7,379.84 | 203,200 | 2020-11-27 | Filing | |
| $2.01 | 8,435 | $16,954.35 | 12,088 | 2020-11-02 | Filing | |
| $0.13 | 19,230,769 | $2,499,999.97 | 130,503,835 | 2016-12-21 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 397,594 | $493,017 | 0% | |
| 2. | 300,000 | $372,000 | 0.24% | |
| 3. | 124,591 | $154,493 | 0% | |
| 4. | 77,619 | $96,248 | 0% | |
| 5. | 66,664 | $82,662 | 0% |
News See All
BioCardia, Inc. (NASDAQ:BCDA) Q4 2025 Earnings Call Transcript
BioCardia, Inc. (NASDAQ:BCDA) Q4 2025 Earnings Call Transcript March 24, 2026BioCardia, Inc. beats earnings expectations. Reported EPS is $-0.06, expectations were $-0.17.
BioCardia, Inc. (NASDAQ:BCDA) Q3 2025 Earnings Call Transcript
BioCardia, Inc. (NASDAQ:BCDA) Q3 2025 Earnings Call Transcript November 12, 2025BioCardia, Inc. beats earnings expectations. Reported EPS is $-0.24, expectations were $-0.25.
BioCardia, Inc. (NASDAQ:BCDA) Q2 2025 Earnings Call Transcript
BioCardia, Inc. (NASDAQ:BCDA) Q2 2025 Earnings Call Transcript August 11, 2025BioCardia, Inc. beats earnings expectations. Reported EPS is $-0.4, expectations were $-0.5.
BioCardia, Inc. (NASDAQ:BCDA) Q1 2025 Earnings Call Transcript
BioCardia, Inc. (NASDAQ:BCDA) Q1 2025 Earnings Call Transcript May 14, 2025BioCardia, Inc. misses on earnings expectations. Reported EPS is $-0.59 EPS, expectations were $-0.39.
BioCardia, Inc. (NASDAQ:BCDA) Q4 2024 Earnings Call Transcript
BioCardia, Inc. (NASDAQ:BCDA) Q4 2024 Earnings Call Transcript March 31, 2025 Operator: Ladies and gentlemen, thank you for standing by.
BioCardia, Inc. (NASDAQ:BCDA) Q3 2024 Earnings Call Transcript
BioCardia, Inc. (NASDAQ:BCDA) Q3 2024 Earnings Call Transcript November 13, 2024 Operator: Good afternoon, ladies and gentlemen. Thank you for standing by.
BioCardia, Inc. (NASDAQ:BCDA) Q2 2024 Earnings Call Transcript
BioCardia, Inc. (NASDAQ:BCDA) Q2 2024 Earnings Call Transcript August 13, 2024BioCardia, Inc. misses on earnings expectations. Reported EPS is $-0.88 EPS, expectations were $-0.1.
BioCardia, Inc. (NASDAQ:BCDA) Q1 2024 Earnings Call Transcript
BioCardia, Inc. (NASDAQ:BCDA) Q1 2024 Earnings Call Transcript May 14, 2024 Operator: Ladies and gentlemen, thank you for standing by.
Insiders Are Buying These 11 Penny Stocks
In this article, we will take a detailed look at Insiders Are Buying These 11 Penny Stocks. For a quick overview of such stocks, read our article Insiders Are Buying These 5 Penny Stocks.
Hedge Fund Resource Center